A precise temperature control during hyperthermic intraperitoneal chemotherapy promises an early return of bowel function

References

• Glockzin G, Ghali N, Lang SA, Agha A, Schlitt HJ, Piso P. 2007. Peritoneal carcinomatosis. Surgical treatment, including hyperthermal intraperitoneal chemotherapy. Chirurg. 78(12):1100,1102–1106, 1108–1110. DOI:10.1007/s00104-007-1419-0.
   PubMedGoogle Scholar
• Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, Fontaumard E, Brachet A, Caillot JL, Faure JL, et al. 2000. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 88(2):358–363. DOI:10.1002/(sici)1097-0142(20000115)88:2<358::aid-cncr16>3.0.co;2-o
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. 2012. Parietal peritonectomy. Ann Surg Oncol. 19(4):1250. DOI:10.1245/s10434-012-2229-2.
   PubMed Web of Science ®Google Scholar
• Gilly FN, Carry PY, Sayag AC, Brachet A, Panteix G, Salle B, Bienvenu J, Burgard G, Guibert B, Banssillon V, et al. 1994. Regional chemotherapy (with mitomycin C) and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis.. Hepatogastroenterology. 41(2):124–129.
   PubMedGoogle Scholar
• Dunn D. 2010. Surgical treatment of patients with peritoneal surface malignancy: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. J Wound, Ostomy Continence Nurs. 37(4):379–385. DOI:10.1097/WON.0b013e3181e399fe.
   PubMed Web of Science ®Google Scholar
• Wu X-J, Yuan P, Li Z-Y, Bu Z-D, Zhang L-H, Wu A-W, Zong X-L, Li S-X, Shan F, Ji X, et al. 2013. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves the survival of gastric cancer patients with ovarian metastasis and peritoneal dissemination. Tumour Biol. 34(1):463–469. DOI:10.1007/s13277-012-0571-4
   PubMedGoogle Scholar
• Goere D, Malka D, Tzanis D, Gava V, Boige V, Eveno C, Maggiori L, Dumont F, Ducreux M, Elias D, et al. 2013. Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg. 257(6):1065–1071. DOI:10.1097/SLA.0b013e31827e9289
   PubMed Web of Science ®Google Scholar
• Chia CS, You B, Decullier E, Vaudoyer D, Lorimier G, Abboud K, Bereder J-M, Arvieux C, Boschetti G, Glehen O, et al. 2016. Patients with peritoneal carcinomatosis from gastric cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is cure a possibility? Ann Surg Oncol. 23(6):1971–1979. DOI:10.1245/s10434-015-5081-3
   PubMed Web of Science ®Google Scholar
• Kusamura S, Dominique E, Baratti D, Younan R, Deraco M. 2008. Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 98(4):247–252. DOI:10.1002/jso.21051.
   PubMed Web of Science ®Google Scholar
• Elias D, Raynard B, Boige V, Laplanche A, Estphan G, Malka D, Pocard M. 2005. Impact of the extent and duration of cytoreductive surgery on postoperative hematological toxicity after intraperitoneal chemohyperthermia for peritoneal carcinomatosis. J Surg Oncol. 90(4):220–225. DOI:10.1002/jso.20253.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ishibashi H, Takeshita K, Mizumoto A, Hirano M, Sako S, Takegawa S, Takao N, Ichinose M, Yonemura Y, et al. 2016. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal dissemination from small bowel malignancy: results from a single specialized center. Ann Surg Oncol. 23(5):1625–1631. DOI:10.1245/s10434-015-5056-4
   PubMed Web of Science ®Google Scholar
• Harmon RL, Sugarbaker PH. 2005. Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Seminars Surg Oncol. 2(1):3. DOI:10.1186/1477-7800-2-3.
   PubMedGoogle Scholar
• Ye J, Ren Y, Wei Z, Peng J, Chen C, Song W, Tan M, He Y, Yuan Y. 2018. Nephrotoxicity and long-term survival investigations for patients with peritoneal carcinomatosis using hyperthermic intraperitoneal chemotherapy with cisplatin: A retrospective cohort study. Surg Oncol. 27(3):456–461. DOI:10.1016/j.suronc.2018.05.025.
   PubMed Web of Science ®Google Scholar
• Song W, Yuan Y, Wang L, He W, Zhang X, Chen C, Zhang C, Cai S, He Y. 2014. The prognostic value of lymph nodes dissection number on survival of patients with lymph node-negative gastric cancer. Gastroenterol Res Pract. 2014: 603194. DOI:10.1155/2014/603194.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. 2016. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of gastrointestinal cancers with peritoneal metastases: progress toward a new standard of care. Cancer Treat Rev. 48: 42–49. DOI:10.1016/j.ctrv.2016.06.007.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Moreno S, Gonzalez-Bayon LA, Ortega-Perez G. 2010. Hyperthermic intraperitoneal chemotherapy: rationale and technique. World J Gastrointest Oncol. 2(2):68–75. DOI:10.4251/wjgo.v2.i2.68.
   PubMed Web of Science ®Google Scholar
• van Ruth S, Verwaal VJ, Hart AA, van Slooten GW, Zoetmulder FA. Heat penetration in locally applied hyperthermia in the abdomen during intra-operative hyperthermic intraperitoneal chemotherapy. Anticancer Res. 2003;23(2B):1501–1508.
   PubMed Web of Science ®Google Scholar
• Rettenmaier MA, Mendivil AA, Gray CM, Chapman AP, Stone MK, Tinnerman EJ, Goldstein BH. 2015. Intra-abdominal temperature distribution during consolidation hyperthermic intraperitoneal chemotherapy with carboplatin in the treatment of advanced stage ovarian carcinoma. Int J Hyperthermia. 31(4):396–402. DOI:10.3109/02656736.2015.1007399.
   PubMed Web of Science ®Google Scholar
• Sticca RP, Dach BW. 2003. Rationale for hyperthermia with intraoperative intraperitoneal chemotherapy agents. Surg Oncol Clin N Am. 12(3):689–701. DOI:10.1016/s1055-3207(03)00029-2.
   PubMedGoogle Scholar
• de Bree E, Tsiftsis DD. 2007. Principles of perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis. Recent Results Cancer Res. 169: 39–51. DOI:10.1007/978-3-540-30760-0_4.
   PubMedGoogle Scholar
• Benoit L, Duvillard C, Rat P, Chauffert B. 1999. The effect of intra-abdominal temperature on the tissue and tumor diffusion of intraperitoneal cisplatin in a model of peritoneal carcinomatosis in rats. Chirurgie. 124(4):375–379. DOI:10.1016/s0001-4001(00)80009-4.
   PubMedGoogle Scholar
• Zunino B, Rubio-Patino C, Villa E, Meynet O, Proics E, Cornille A, Pommier S, Mondragon L, Chiche J, Bereder J-M, et al. 2016. Hyperthermic intraperitoneal chemotherapy leads to an anticancer immune response via exposure of cell surface heat shock protein 90. Oncogene. 35(2):261–268. DOI:10.1038/onc.2015.82
   PubMed Web of Science ®Google Scholar
• Furman MJ, Picotte RJ, Wante MJ, Rajeshkumar BR, Whalen GF, Lambert LA. 2014. Higher flow rates improve heating during hyperthermic intraperitoneal chemoperfusion. J Surg Oncol. 110(8):970–975. DOI:10.1002/jso.23776.
   PubMed Web of Science ®Google Scholar